(Q37848667)

24 August 2017

1 reference

title

Biomarker studies: a call for a comprehensive biomarker study registry (English)

1 reference

24 August 2017

0 references

5

Douglas G Altman

1 reference

24 August 2017

Stefan Michiels

3

0 references

Jorge Reis-Filho

6

object named as

Jorge S Reis-Filho

1 reference

24 August 2017

Fabrice Andre

1

1 reference

24 August 2017

Lisa M McShane

2

1 reference

24 August 2017

David F Ransohoff

4

1 reference

24 August 2017

Daniel F Hayes

7

1 reference

24 August 2017

Lajos Pusztai

8

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

Nature Reviews Clinical Oncology

24 August 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 August 2017

8

1 reference

24 August 2017

3

1 reference

24 August 2017

171-176

1 reference

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2011.4

24 August 2017

0 references

cites work

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Design and implementation of a national clinical trials registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Primer: an evidence-based approach to prognostic markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Use of archived specimens in evaluation of prognostic and predictive biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Development and validation of therapeutically relevant multi-gene biomarker classifiers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Statistical aspects of prognostic factor studies in oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Dissemination and publication of research findings: an updated review of related biases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Selective reporting biases in cancer prognostic factor studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Trial Registration at ClinicalTrials.gov between May and October 2005

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Comparison of registered and published primary outcomes in randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Registration of observational studies: is it time?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Why most published research findings are false

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

CXCR4 expression in early breast cancer and risk of distant recurrence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.4

31 March 2020

Identifiers

DOI

10.1038/NRCLINONC.2011.4

1 reference

Dimensions Publication ID

24 August 2017

0 references

1 reference